REQUEST A DEMO
Total
USD $0.00
Search more companies

BioDlink International Company Limited (东曜药业股份有限公司) (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: BioDlink International Company Limited Profile Updated: October 23, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

TOT BIOPHARM International Company Limited is a clinical stage biopharmaceutical company dedicated to the development and commercialization of innovative oncology drugs and therapies. The company was founded in 2009 and is headquartered in Suzhou City, China.

Headquarters
120 Changyang Street, Suzhou Industrial Park
Suzhou; Jiangsu;

Contact Details: Purchase the BioDlink International Company Limited (东曜药业股份有限公司) report to view the information.

Website: http://www.biodlink.com

Basic Information
Total Employees:
Purchase the BioDlink International Company Limited (东曜药业股份有限公司) report to view the information.
Outstanding Shares:
Purchase the BioDlink International Company Limited (东曜药业股份有限公司) report to view the information.
Financial Auditors:
Purchase the BioDlink International Company Limited (东曜药业股份有限公司) report to view the information.
Incorporation Date:
December 08, 2025
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
28.59%
Purchase this report to view the information.
15.04%
Purchase this report to view the information.
11.74%
Purchase this report to view the information.
7.32%
Purchase this report to view the information.
6.36%
Subsidiaries
Shengyang Biopharm (Hong Kong) Limited (China)
100%
Tot Biopharm Co., Ltd (China)
100%
Tot Biopharm Company Limited (Taiwan, China)
100%
Company Performance
Financial values in the chart are available after BioDlink International Company Limited (东曜药业股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
-7.39%
Total operating revenue
-7.01%
Operating profit (EBIT)
-64.11%
EBITDA
-13.6%
Net Profit (Loss) for the Period
-87.31%
Total assets
1.44%
Total equity
1.16%
Operating Profit Margin (ROS)
-2.8%
Net Profit Margin
-5.23%
Return on Equity (ROE)
-3.8%
Debt to Equity Ratio
1.25%
Quick Ratio
0.05%
Cash Ratio
0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?